New imaging techniques for analyzing tumors and tissues in cancer diagnosis
Official title: Adaptive imaging for pioneering multiplexed spatial profiling of tumors and tissues for cancer research and diagnosis
Funded at Rarecyte, INC. · NIH-11066603 · Data updated 2026-11-12
This study is working on new ways to take better pictures of tumors and tissues to help doctors understand cancer more clearly, which could lead to more tailored treatments just for you.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rarecyte, INC. NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | June 1, 2025 |
| Project end | May 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $658,336 |
| NIH project number | 1R44CA298064-01 |
| Project ID | NIH-11066603 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with various types of cancer who are undergoing tissue analysis for treatment planning.
✕Less likely to help
Patients with cancers that do not require detailed histopathological analysis or those who are not undergoing tissue sampling may not benefit from this research.
What this research studies
This research aims to enhance cancer diagnosis by developing advanced imaging techniques that allow for the detailed analysis of tumors and tissues. It combines innovative methods to quantify multiple protein markers in tissue samples with machine learning and artificial intelligence to interpret these images effectively. By focusing on the most informative areas of tissue samples, this approach seeks to provide a more comprehensive understanding of cancer at a cellular level, which could lead to more personalized treatment plans for patients.
Why it matters
Potential benefit: If successful, this research could lead to more accurate cancer diagnoses and better-targeted therapies for patients.
How similar studies have gone: Other research has shown promising results using similar advanced imaging techniques and AI approaches in cancer diagnostics.
Where this research is happening
-
Rarecyte, INC.
Seattle, United States Active
Researchers
- Principal investigator: George, Tad — Rarecyte, INC.
- Study coordinator: George, Tad
Related research
Other NIH-funded projects on the same topics.
-
Adaptive imaging to map cancer tissues with highly multiplexed 3D profiles
A new imaging method to capture highly detailed, multi-marker pictures of tumors and surrounding tissue to help doctors diagnose and plan cancer treatments.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.